-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NTyVIo0RQx6EQ4DfWyjPFe2V3KWwTPhUG8w10SnuIfgMFsVxTYEmoOHOi3Jnt1u9 8bCTxzG4xQsIiAV5SzcQ3g== 0000875320-07-000118.txt : 20071205 0000875320-07-000118.hdr.sgml : 20071205 20071205122116 ACCESSION NUMBER: 0000875320-07-000118 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071204 FILED AS OF DATE: 20071205 DATE AS OF CHANGE: 20071205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOGER JOSHUA S CENTRAL INDEX KEY: 0001197023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 071285974 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2007-12-04 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197023 BOGER JOSHUA S C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139 1 1 0 0 President & CEO Common Stock 2007-12-04 4 M 0 17500 13.67 A 1113342 D Common Stock 2007-12-04 4 S 0 1200 25.16 D 1112142 D Common Stock 2007-12-04 4 S 0 7600 25.04 D 1104542 D Common Stock 2007-12-04 4 S 0 5700 24.96 D 1098842 D Common Stock 2007-12-04 4 S 0 2700 24.84 D 1096142 D Common Stock 2007-12-04 4 S 0 300 24.74 D 1095842 D Common Stock 12445 I 401(k) Common Stock 207500 I Shares in trust Stock Option 13.67 2007-12-04 4 M 0 17500 0 D 2007-12-11 Common Stock 17500 35186 D Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. Aggregate sales made at prices between $25.10 and $25.20. Aggregate sales made at prices between $25.00 and $25.09. Aggregate sales made at prices between $24.90 and $24.99. Aggregate sales made at prices between $24.80 and $24.89. Aggregate sales made at prices between $24.72 and $24.77. Fully vested. Shares held in trust for Dr. Boger's children. Dr. Boger disclaims beneficial ownership of such shares. Valerie L. Andrews, Attorney-In-Fact 2007-12-05 -----END PRIVACY-ENHANCED MESSAGE-----